Residual exercise SPECT ischemia on treatment is a main determinant of outcome in patients with coronary artery disease treated medically at long-term with β-blockers

Journal of Nuclear Cardiology

Volumn 10, Issue 4, 2003, Pages 361-368

  Marie, Pierre Y ^a,b   Mercennier, Christelle ^a,b   Danchin, Nicolas ^a,b   Djaballah, Karim ^a,b   Grentzinger, Alain ^a,b   Zannad, Faïez ^a,b   Olivier, Pierre ^a,b   Djaballah, Wassila ^a,b   Karcher, Gilles ^a,b   Virion, Jean M ^a,b   Bertrand, Alain ^a,b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Coronary artery disease; Prognosis; Single photon emission computed tomography; Thallium 201; blockers

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THALLIUM 201;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DRUG POTENCY; DRUG USE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MULTIVARIATE ANALYSIS; PATIENT REFERRAL; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0042035620     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(03)00429-X     Document Type: Article

References (20)

1. Freemantle N, Cleland J, Young P, et al. Beta-blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999;318:1730-8.
2. The Australia-New Zealand Carvedilol Study Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet 1997;349:375-80.
3. Kendall MJ, Lynch KP, Hjalmarson A, et al. β-Blockers and sudden cardiac death. Ann Intern Med 1995;123:358-67.
4. Rainwater J, Steele P, Kirch D, et al. Effect of propanolol on myocardial perfusion images and exercise ejection fraction in men with coronary artery disease. Circulation 1982;65:77-81.
5. Hockings B, Saftissi S, Croft DN, et al. Effect of beta adrenergic blockade on thallium-201 myocardial perfusion imaging. Br Heart J 1983;49:83-9.
6. Stegaru B, Loose R, Keller H, et al. Effects of long-term treatment with 120 mg of sustained-release isosorbide dinitrate and 60 mg of sustained-release nifedipine on myocardial perfusion. Am J Cardiol 1988;61:74E-7E.
7. Göller V, Clausen M, Henze E, et al. Reduction of exercise-induced myocardial perfusion defects by isosorbide-5-nitrate: assessment using quantitative Tc-99m-MIBI-SPECT. Coron Artery Dis 1995;6:245-9.
8. Madias JE, Lee VW, Song SS. Acute effects of oral isosorbide dinitrate on exercise thallium-201 myocardial imaging in patients with stable angina pectoris. A randomized double-blind placebo-controlled clinical trial. Am J Noninvasive Cardiol 1992;6:215-23.
9. Marie PY, Danchin N, Branly F, et al. Effects of medical therapy on outcome assessment using exercise thallium-201 single photon emission computed tomography imaging: evidence of a protective effect of β-blocking antianginal medications. J Am Coll Cardiol 1999;34:113-21.
10. Dilsizian V, Rocco TP, Freedman NMT, et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6.
11. Marie PY, Angioï M, Danchin N, et al. Assessment of myocardial viability in patients with previous myocardial infarction by using single-photon emission computed tomography with a new metabolic tracer: [123-I]-16-iodo-methylhexadecanoic acid. J Am Coll Cardiol 1997;30:1241-8.
12. Abdel Fattah A, Kamal AM, Pancholy S, et al. Prognostic implications of normal exercise tomographic thallium images in patients with angiographic evidence of significant coronary artery disease. Am J Cardiol 1994;74:769-71.
13. Brown KA, Rowen M. Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. Am J Cardiol 1993;71:865-7.
14. Parisi AF, Hartigan PM, Folland ED. Evaluation of exercise thallium scintigraphy versus exercise electrocardiography in predicting survival outcomes and morbid cardiac events in patients with single- and double-vessel disease. Findings from the Angioplasty Compared to Medicine (ACME) study. J Am Coll Cardiol 1997;30:1256-63.
15. Verzijlbergen JF, Vermeersch PH, Laarman CJ, et al. Inadequate exercise leads to suboptimal imaging. Thallium-201 myocardial perfusion imaging after dipyridamole combined with low-level exercise unmasks ischemia in symptomatic patients with non-diagnostic thallium-201 scans who exercise submaximally. J Nucl Med 1991;32:2071-8.
16. Dakik HA, Kleiman NS, Farmer JA, et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation 1998;98:2017-23.
17. 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995;92:334-41.
18. Miller TD, Hodge DO, Sutton JM, et al. Usefulness of technetium-99m sestamibi infarct size in predicting posthospital mortality following acute myocardial infarction. Am J Cardiol 1998;81: 1491-3.
19. Sharir T, Germano G, Kavanagh PB, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999;100:1035-42.
20. Davies RF, Goldberg AD, Forman S, et al. Asymptornatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037-43.